Provided by Tiger Trade Technology Pte. Ltd.

Ventyx Biosciences, Inc.

7.94
-1.4400-15.35%
Post-market: 8.000.0600+0.76%16:53 EST
Volume:4.61M
Turnover:38.15M
Market Cap:566.59M
PE:-5.30
High:8.89
Open:8.88
Low:7.61
Close:9.38
52wk High:10.55
52wk Low:0.7830
Shares:71.36M
Float Shares:53.56M
Volume Ratio:4.35
T/O Rate:8.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.4991
EPS(LYR):-1.9732
ROE:-45.35%
ROA:-28.47%
PB:2.96
PE(LYR):-4.02

Loading ...

BRIEF-Ventyx Provides Clinical And Corporate Updates

Reuters
·
Yesterday

Ventyx Biosciences Expands Phase 2 Recurrent Pericarditis Study Into Canada, EU, UK

MT Newswires Live
·
Yesterday

Ventyx Biosciences Inc: Revising Guidance for Topline Data Release From Interim Analysis of Phase 2 Rp Trial to Q1 2026

THOMSON REUTERS
·
Yesterday

Ventyx Provides Clinical and Corporate Updates

GlobeNewswire
·
Yesterday

Analyst Sees Value In Neumora's Expanding Obesity And Metabolic Pipeline

Benzinga
·
Yesterday

Ventyx Biosciences to Join Piper Sandler Annual Healthcare Conference

Reuters
·
Dec 01

Ventyx Biosciences Q3 EPS USD -0.32

Reuters
·
Nov 20

Ventyx Biosciences to Join Jefferies Global Healthcare Conference in London

Reuters
·
Nov 17

Ventyx Biosciences Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Nov 08

Promising Pipeline and Data Updates Justify Buy Rating for Ventyx Biosciences

TIPRANKS
·
Nov 07

Stock Track | Ventyx Biosciences (VTYX) Plummets 5.47% Pre-Market Despite Analyst Upgrades, Q3 Earnings May Disappoint

Stock Track
·
Nov 07

Ventyx Biosciences price target raised to $16 from $14 at Canaccord

TIPRANKS
·
Nov 07

Ventyx Biosciences Inc : Canaccord Genuity Raises Target Price to $16 From $14

THOMSON REUTERS
·
Nov 07

Ventyx Biosciences Reports Q3 2025 Financial Results

TIPRANKS
·
Nov 07

Ventyx Biosciences Q3 EPS $(0.32) Beats $(0.45) Estimate

Benzinga
·
Nov 07

Ventyx Biosciences Q3 net loss narrows to $22.8 mln

Reuters
·
Nov 07

BRIEF-Ventyx Biosciences Q3 EPS USD -0.32

Reuters
·
Nov 07

Ventyx Biosciences Reports Third Quarter 2025 Financial Results and Highlights Recent Corporate Progress

THOMSON REUTERS
·
Nov 07

Ventyx Biosciences Shares Rise After HC Wainwright Upgrade

MT Newswires Live
·
Nov 06

HC Wainwright Upgrades Ventyx Biosciences to Buy From Neutral, $18 Price Target

MT Newswires Live
·
Nov 05